Phenomics Health
Plymouth, US · 1 known investors
Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.
Founders & leadership
BD
Brian D. AtheyCo-founder
PW
Pamela WeirNamed on SEC filing
LW
Lew WallaceNamed on SEC filing
FD
F. David ParkerNamed on SEC filing
JM
Jarrett MillsapsNamed on SEC filing
JS
James S. BurnsFounder
DJ
Daniel JasewiczinCompany Leadership (Strategy & Commercialization)
GH
Gerry HigginsinScientific Strategy Lead
WC
Wenbing CheninLaboratory Director
AA
Alex AdeinTechnology & Data Science Lead
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.5M disclosed across 1 round · 2022
▶$11.5MraisedOct 2022 · 33 investors · OtherRule 506(b)
▶$11.5MraisedOct 2022 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Pamela WeirDirector
- Lew WallaceDirector
- F. David ParkerDirector
- Jarrett MillsapsDirector
- James S. BurnsExecutive Officer, Director
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapGenomics Plc18 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Phinomics14 shared keywordsPhinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
Phenomic AI14 shared keywordsPhenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
Phenomix Sciences10 shared keywords
NeoGenomics9 shared keywordsNeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
Tagomics9 shared keywordsTagomics is focused on organ health, though the available page content does not provide enough detail about its products, technology, or business model.
Helix7 shared keywordsHelix operates a precision health platform connecting patients, physicians, health systems, and life sciences organizations to genetic testing and genomic data. Its offerings include clinical genetic testing (Helix Diagnostics), population genomics (Helix Research Network), a clinico-genomic research database (GenoSphere), and cost-management tools for health plans.
Companies competing with Phenomics Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Phenomics Health do?
- Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.
- Who founded Phenomics Health?
- Phenomics Health was founded by Brian D. Athey.
- Who are Phenomics Health's investors?
- Phenomics Health's investors include Solas BioVentures.
- How much funding has Phenomics Health raised?
- Phenomics Health has disclosed $11.5M raised across 1 round.
- Where is Phenomics Health headquartered?
- Phenomics Health is headquartered in Plymouth, US.